Cargando…
Rapid‐acting antidepressant ketamine, its metabolites and other candidates: A historical overview and future perspective
Major depressive disorder (MDD) is one of the most disabling psychiatric disorders. Approximately one‐third of the patients with MDD are treatment resistant to the current antidepressants. There is also a significant therapeutic time lag of weeks to months. Furthermore, depression in patients with b...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley & Sons Australia, Ltd
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6851782/ https://www.ncbi.nlm.nih.gov/pubmed/31215725 http://dx.doi.org/10.1111/pcn.12902 |